Oral bioavailability of gatifloxacin in healthy volunteers under fasting and fed conditions

Chemotherapy

Volumn 48, Issue 3, 2002, Pages 111-115

  Mignot, Alain ^a   Guillaume, Michel ^a   Göhler, Karin ^b   Stahlberg, Hans Jürgen ^b  

^a Aster Cephac   (France)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TOLERANCE; ELECTROCARDIOGRAM; FEEDING; FOOD INTAKE; HUMAN; MALE; MEAL; NORMAL HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BIOAVAILABILITY; EATING; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; BIOLOGICAL AVAILABILITY; EATING; FASTING; HUMAN; MALE; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS;

EID: 0035986308     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064914     Document Type: Article

References (22)

1. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone
2. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
3. Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods
4. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms
5. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae
6. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae
7. Antibacterial properties of AM-1155, a new 8-methoxy quinolone
8. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans
9. Single dose pharmacokinetics of the R- and S-enantiomers of gatifloxacin in volunteers
10. High performance liquid chromatographic determination of gatifloxacin, a new quinolone, in biological fluids
11. Interchangeability of 400 mg intravenous and oral gatifloxacin in healthy adults
12. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man
13. Oral bioavailability of trovafloxacin with and without food in healthy volunteers
14. Bioavailability and pharmacoki-netics of ofloxacin in healthy volunteers
15. The quinolones. An overview of their pharmacology
16. Quinolone antimicrobial agents
17. Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminium and magnesium
18. Interactions of fluoroquinolones with other drugs: Mechanisms, variability, clinical significance, and management
19. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: Effect of food and antacid intake
20. Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin
21. Effect of food on enoxacin absorption